GLP‑1 treatment in Florida
Who ships GLP-1 medication to Florida, what Medicaid covers, and the telehealth rules that apply.
What the federal data shows for Florida
19,356 clinicians in Florida prescribed Ozempic to Medicare Part D patients in 2024, across 721,821 claims. That is the most-prescribed GLP-1 in the state by prescriber count. Part D covers Medicare only, so the figure is a floor on prescribing in Florida rather than a total.
Florida Medicaid reimbursed $29,922,471.09 for 29,680 GLP-1 prescriptions in Q1 2026, or $1,008.17 per prescription. From CMS State Drug Utilization, fee-for-service and managed care combined. Suppressed cells are excluded, never counted as zero.
15 outsourcing facilities registered with the FDA under section 503B give a Florida address, and 7 of them have no recorded FDA inspection. Registration is a filing, not an approval, and an uninspected facility has not passed an inspection — it has not had one. Each one has a page in the 503B register.
What is on this page
- 7 drug cost pages for Florida, each pairing the state's Medicaid figures with pharmacy acquisition cost
- 27 city pages showing where GLP-1 prescribers practise in Florida
- Every link below is a page for Florida specifically, not a national page filtered to it
- CMS NADACNational Average Drug Acquisition Cost, weekly file
- CMS Medicare Part DPrescriber public use file, by geography and drug
- CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement data
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.